Krishmita Siwakoti is an Endocrinology/Metabolic physician affiliated with University of Alabama at Birmingham. OpenAlex indexes 33 publications with 529 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
81%GLP-1 receptor agonist40.8%Ozempic47%Mounjaro40%Trulicity11%Rybelsus3%Part D<11 patientsInsulin Analog26.6%Lantus Solostar32%Novolog Flexpen13%Tresiba Flextouch U-10013%Humalog Kwikpen U-10011%Basaglar Kwikpen U-1009%Humalog8%Toujeo Solostar7%Novolog5%Insulin Lispro Kwikpen U-1003%Part D<11 patients+ 5 more classes in this area
Hormonal (systemic)
6.5%l-Thyroxine4.1%Levothyroxine Sodium100%Part D≥18 patientsMineralocorticoids1.3%Fludrocortisone Acetate100%Part D<11 patients+ 1 more class in this area
Genitourinary & hormones
4.4%Androgen2.3%Testosterone100%Part D<11 patientsEstrogen2%Estradiol56%Dotti44%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The Impact of Testosterone Therapy on the Vaginal Microbiota of Transgender Men and Nonbinary People: A Prospective Study
The Journal of Infectious Diseases
2025 - Application of Photon-Derived Worst-Case Robustness Criteria to Proton Therapy Planning
International Journal of Particle Therapy
2025 - Rational approach to proton therapy robustness evaluation in prostate cancer using a photon therapy planning benchmark
International Journal of Particle Therapy
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Suzanne Oparil, MD
University of Alabama at Birmingham
Richard Whitley, MD
University of Alabama at Birmingham
David Standaert, MD, PhD
University of Alabama at Birmingham
Bruce Korf, MD
University of Alabama at Birmingham
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”